LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article: Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis.

    Abdullahi, Auwal / Candan, Sevim Acaroz / Abba, Muhammad Aliyu / Bello, Auwal Hassan / Alshehri, Mansour Abdullah / Afamefuna Victor, Egwuonwu / Umar, Naima Aliyu / Kundakci, Burak

    Frontiers in neurology

    2020  Volume 11, Page(s) 687

    Abstract: Importance: ...

    Abstract Importance:
    Keywords covid19
    Language English
    Publishing date 2020-06-26
    Publishing country Switzerland
    Document type Systematic Review
    ZDB-ID 2564214-5
    ISSN 1664-2295
    ISSN 1664-2295
    DOI 10.3389/fneur.2020.00687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis

    Abdullahi, A. / Candan, S. A. / Abba, M. A. / Bello, A. H. / Alshehri, M. A. / Afamefuna Victor, E. / Umar, N. A. / Kundakci, B.

    Frontiers in neurology

    Abstract: ... musculoskeletal features Result: Sixty studies (n = 11, 069) were included in the review, and 51 studies were used ... 95% CI 1-2%;I (2) 0%) Conclusion and Relevance: Patients with COVID-19 present with neurological and ... Importance: Some of the symptoms of COVID-19 are fever, cough, and breathing difficulty ...

    Abstract Importance: Some of the symptoms of COVID-19 are fever, cough, and breathing difficulty However, the mechanism of the disease, including some of the symptoms such as the neurological and musculoskeletal symptoms, is still poorly understood Objective: The aim of this review is to summarize the evidence on the neurological and musculoskeletal symptoms of the disease This may help with early diagnosis, prevention of disease spread, and treatment planning Data Sources: MEDLINE, EMBASE, Web of Science, and Google Scholar (first 100 hits) were searched until April 17, 2020 The key search terms used were "coronavirus" and "signs and symptoms " Only studies written in English were included Study Selection: The selection was performed by two independent reviewers using EndNote and Rayyan software Any disagreement was resolved by consensus or by a third reviewer Data Extraction and Synthesis: PRISMA guidelines were followed for abstracting data and assessing the quality of the studies These were carried out by two and three independent reviewers, respectively Any disagreement was resolved by consensus or by a third reviewer The data were analyzed using qualitative synthesis and pooled using a random-effect model Main Outcome(s) and Measure(s): The outcomes in the study include country, study design, participant details (sex, age, sample size), and neurological and musculoskeletal features Result: Sixty studies (n = 11, 069) were included in the review, and 51 studies were used in the meta-analysis The median or mean age ranged from 24 to 95 years The prevalence of neurological and musculoskeletal manifestations was 35% for smell impairment (95% CI 0-94%;I (2) 99 63%), 33% for taste impairment (95% CI 0-91%;I (2) 99 58%), 19% for myalgia (95% CI 16-23;I (2) 95%), 12% for headache (95% CI 9-15;I (2) 93 12%), 10% for back pain (95% CI 1-23%;I (2) 80 20%), 10% for dizziness (95% CI 3-19%;I (2) 86 74%), 3% for acute cerebrovascular disease (95% CI 1-5%;I (2) 0%), and 2% for impaired consciousness (95% CI 1-2%;I (2) 0%) Conclusion and Relevance: Patients with COVID-19 present with neurological and musculoskeletal symptoms Therefore, clinicians need to be vigilant in the diagnosis and treatment of these patients
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #647818
    Database COVID19

    Kategorien

  3. Article ; Online: Persistent neurological manifestations in long COVID-19 syndrome

    Rizaldy Taslim Pinzon / Vincent Ongko Wijaya / Abraham Al Jody / Patrick Nalla Nunsio / Ranbebasa Bijak Buana

    Journal of Infection and Public Health, Vol 15, Iss 8, Pp 856-

    A systematic review and meta-analysis

    2022  Volume 869

    Abstract: ... neurological manifestations after COVID-19. Objective: To conduct a systematic review and meta-analysis on the persistent ... sources by reviewing related references. Studies presenting the neurologic features of long COVID-19 ... review and meta-analysis of these studies are required to understanding the prevalence of persistent ...

    Abstract Background: Several studies have reported prolonged symptoms especially neurological symptoms following acute infection in patients with COVID-19, known as long COVID-19. There are only few studies investigating this population and relatively less known, including nervous system involvement. A systematic review and meta-analysis of these studies are required to understanding the prevalence of persistent neurological manifestations after COVID-19. Objective: To conduct a systematic review and meta-analysis on the persistent neurological manifestations in COVID-19 survivors. Methods: Authors conducted a literature search through PubMed and MedRxiv from January 1st, 2020 to October 2021 according to PRISMA guideline. Furthermore, the authors added additional sources by reviewing related references. Studies presenting the neurologic features of long COVID-19 patients in their data were included. Case reports and case series also included in this review. The quality of the studies was assessed based on the Oxford Centre for Evidence-Based Medicine guidelines. Selected studies were included in the meta-analysis of proportion and heterogeneity test. Findings: From 128 identified studies, 36 were eligible, with 9944 participants included. Most of the included studies had mean duration of follow-up after COVID-19 onset of less than 6 months. Fatigue was the most common (52.8%, 95%CI 19.9 – 84.4) symptoms of long COVID, followed by cognitive disorder (35.4%, 95%CI 2.1 – 81.7); paresthesia (33.3%, 95%CI 2.7 – 76.6); sleep disorder (32.9%, 95%CI 6.5 – 67.4); musculoskeletal pain (27.8%, 95%CI 12.7 – 46); and dizziness (26.4%, 95%CI 4.6 – 57.9). Conclusion: Neurological manifestations are prevalent and persisting in patients with long COVID. The duration of the symptoms are vary among literatures. However, the frequency are mostly observed during the first six months after the illness onset.
    Keywords Neurology ; Long covid ; Manifestation ; Infectious and parasitic diseases ; RC109-216 ; Public aspects of medicine ; RA1-1270
    Subject code 150
    Language English
    Publishing date 2022-08-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis.

    Pinzon, Rizaldy Taslim / Wijaya, Vincent Ongko / Jody, Abraham Al / Nunsio, Patrick Nalla / Buana, Ranbebasa Bijak

    Journal of infection and public health

    2022  Volume 15, Issue 8, Page(s) 856–869

    Abstract: ... neurological manifestations after COVID-19.: Objective: To conduct a systematic review and meta-analysis on the persistent ... review and meta-analysis of these studies are required to understanding the prevalence of persistent ... neurological manifestations in COVID-19 survivors.: Methods: Authors conducted a literature search through PubMed and ...

    Abstract Background: Several studies have reported prolonged symptoms especially neurological symptoms following acute infection in patients with COVID-19, known as long COVID-19. There are only few studies investigating this population and relatively less known, including nervous system involvement. A systematic review and meta-analysis of these studies are required to understanding the prevalence of persistent neurological manifestations after COVID-19.
    Objective: To conduct a systematic review and meta-analysis on the persistent neurological manifestations in COVID-19 survivors.
    Methods: Authors conducted a literature search through PubMed and MedRxiv from January 1st, 2020 to October 2021 according to PRISMA guideline. Furthermore, the authors added additional sources by reviewing related references. Studies presenting the neurologic features of long COVID-19 patients in their data were included. Case reports and case series also included in this review. The quality of the studies was assessed based on the Oxford Centre for Evidence-Based Medicine guidelines. Selected studies were included in the meta-analysis of proportion and heterogeneity test.
    Findings: From 128 identified studies, 36 were eligible, with 9944 participants included. Most of the included studies had mean duration of follow-up after COVID-19 onset of less than 6 months. Fatigue was the most common (52.8%, 95%CI 19.9 - 84.4) symptoms of long COVID, followed by cognitive disorder (35.4%, 95%CI 2.1 - 81.7); paresthesia (33.3%, 95%CI 2.7 - 76.6); sleep disorder (32.9%, 95%CI 6.5 - 67.4); musculoskeletal pain (27.8%, 95%CI 12.7 - 46); and dizziness (26.4%, 95%CI 4.6 - 57.9).
    Conclusion: Neurological manifestations are prevalent and persisting in patients with long COVID. The duration of the symptoms are vary among literatures. However, the frequency are mostly observed during the first six months after the illness onset.
    MeSH term(s) COVID-19/complications ; Coronavirus Infections/epidemiology ; Humans ; Pandemics ; Pneumonia, Viral/epidemiology
    Language English
    Publishing date 2022-06-23
    Publishing country England
    Document type Journal Article ; Meta-Analysis ; Review ; Systematic Review
    ZDB-ID 2467587-8
    ISSN 1876-035X ; 1876-0341
    ISSN (online) 1876-035X
    ISSN 1876-0341
    DOI 10.1016/j.jiph.2022.06.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Neurological and Musculoskeletal Features of COVID-19

    Abdullahi, Auwal / Candan, Sevim Acaroz / Abba, Muhammad Aliyu / Bello, Auwal Hassan / Alshehri, Mansour Abdullah / Afamefuna Victor, Egwuonwu / Umar, Naima Aliyu / Kundakci, Burak

    Frontiers in Neurology

    A Systematic Review and Meta-Analysis

    2020  Volume 11

    Keywords Neurology ; Clinical Neurology ; covid19
    Publisher Frontiers Media SA
    Publishing country ch
    Document type Article ; Online
    ZDB-ID 2564214-5
    ISSN 1664-2295
    ISSN 1664-2295
    DOI 10.3389/fneur.2020.00687
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Neurological and musculoskeletal features of COVID-19

    Abdullahi, Auwal / Candan, Sevim Acaroz / Abba, Muhammad Aliyu / Bello, Auwal Hassan / Alshehri, Mansour Abdullah / Afamefuna Victor, Egwuonwu / Umar, Naima Aliyu / Kundakci, Burak

    a systematic review and meta-analysis

    2020  

    Abstract: ... musculoskeletal features. Result: Sixty studies (n = 11, 069) were included in the review, and 51 studies were ... CI 1–2%; I 0%). Conclusion and Relevance: Patients with COVID-19 present with neurological and ... Importance: Some of the symptoms of COVID-19 are fever, cough, and breathing difficulty ...

    Abstract Importance: Some of the symptoms of COVID-19 are fever, cough, and breathing difficulty. However, the mechanism of the disease, including some of the symptoms such as the neurological and musculoskeletal symptoms, is still poorly understood. Objective: The aim of this review is to summarize the evidence on the neurological and musculoskeletal symptoms of the disease. This may help with early diagnosis, prevention of disease spread, and treatment planning. Data Sources: MEDLINE, EMBASE, Web of Science, and Google Scholar (first 100 hits) were searched until April 17, 2020. The key search terms used were “coronavirus” and “signs and symptoms.” Only studies written in English were included. Study Selection: The selection was performed by two independent reviewers using EndNote and Rayyan software. Any disagreement was resolved by consensus or by a third reviewer. Data Extraction and Synthesis: PRISMA guidelines were followed for abstracting data and assessing the quality of the studies. These were carried out by two and three independent reviewers, respectively. Any disagreement was resolved by consensus or by a third reviewer. The data were analyzed using qualitative synthesis and pooled using a random-effect model. Main Outcome(s) and Measure(s): The outcomes in the study include country, study design, participant details (sex, age, sample size), and neurological and musculoskeletal features. Result: Sixty studies (n = 11, 069) were included in the review, and 51 studies were used in the meta-analysis. The median or mean age ranged from 24 to 95 years. The prevalence of neurological and musculoskeletal manifestations was 35% for smell impairment (95% CI 0–94%; I 99.63%), 33% for taste impairment (95% CI 0–91%; I 99.58%), 19% for myalgia (95% CI 16–23; I 95%), 12% for headache (95% CI 9–15; I 93.12%), 10% for back pain (95% CI 1–23%; I 80.20%), 10% for dizziness (95% CI 3–19%; I 86.74%), 3% for acute cerebrovascular disease (95% CI 1–5%; I 0%), and 2% for impaired consciousness (95% CI 1–2%; I 0%). Conclusion and Relevance: Patients with COVID-19 present with neurological and musculoskeletal symptoms. Therefore, clinicians need to be vigilant in the diagnosis and treatment of these patients.
    Keywords Anosmia ; COVID-19 ; Cytokine storm ; Headache ; Muscle weakness ; Myalgia ; Symptoms ; Taste impairment ; covid19
    Subject code 150
    Language English
    Publishing date 2020-06-26
    Publisher Frontiers Research Foundation
    Publishing country au
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Neurological and Musculoskeletal Features of COVID-19

    Auwal Abdullahi / Sevim Acaroz Candan / Muhammad Aliyu Abba / Auwal Hassan Bello / Mansour Abdullah Alshehri / Egwuonwu Afamefuna Victor / Naima Aliyu Umar / Burak Kundakci

    Frontiers in Neurology, Vol

    A Systematic Review and Meta-Analysis

    2020  Volume 11

    Abstract: ... musculoskeletal features.Result: Sixty studies (n = 11, 069) were included in the review, and 51 studies were used ... Conclusion and Relevance: Patients with COVID-19 present with neurological and musculoskeletal symptoms ... Importance: Some of the symptoms of COVID-19 are fever, cough, and breathing difficulty ...

    Abstract Importance: Some of the symptoms of COVID-19 are fever, cough, and breathing difficulty. However, the mechanism of the disease, including some of the symptoms such as the neurological and musculoskeletal symptoms, is still poorly understood.Objective: The aim of this review is to summarize the evidence on the neurological and musculoskeletal symptoms of the disease. This may help with early diagnosis, prevention of disease spread, and treatment planning.Data Sources: MEDLINE, EMBASE, Web of Science, and Google Scholar (first 100 hits) were searched until April 17, 2020. The key search terms used were “coronavirus” and “signs and symptoms.” Only studies written in English were included.Study Selection: The selection was performed by two independent reviewers using EndNote and Rayyan software. Any disagreement was resolved by consensus or by a third reviewer.Data Extraction and Synthesis: PRISMA guidelines were followed for abstracting data and assessing the quality of the studies. These were carried out by two and three independent reviewers, respectively. Any disagreement was resolved by consensus or by a third reviewer. The data were analyzed using qualitative synthesis and pooled using a random-effect model. Main Outcome(s) and Measure(s): The outcomes in the study include country, study design, participant details (sex, age, sample size), and neurological and musculoskeletal features.Result: Sixty studies (n = 11, 069) were included in the review, and 51 studies were used in the meta-analysis. The median or mean age ranged from 24 to 95 years. The prevalence of neurological and musculoskeletal manifestations was 35% for smell impairment (95% CI 0–94%; I2 99.63%), 33% for taste impairment (95% CI 0–91%; I2 99.58%), 19% for myalgia (95% CI 16–23; I2 95%), 12% for headache (95% CI 9–15; I2 93.12%), 10% for back pain (95% CI 1–23%; I2 80.20%), 10% for dizziness (95% CI 3–19%; I2 86.74%), 3% for acute cerebrovascular disease (95% CI 1–5%; I2 0%), and 2% for impaired consciousness (95% CI 1–2%; I2 0%).Conclusion and Relevance: Patients with COVID-19 present with neurological and musculoskeletal symptoms. Therefore, clinicians need to be vigilant in the diagnosis and treatment of these patients.
    Keywords COVID-19 ; symptoms ; myalgia ; taste impairment ; anosmia ; cytokine storm ; Neurology. Diseases of the nervous system ; RC346-429 ; covid19
    Subject code 150
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Book ; Online: Data_Sheet_1_Neurological and Musculoskeletal Features of COVID-19

    Auwal Abdullahi / Sevim Acaroz Candan / Muhammad Aliyu Abba / Auwal Hassan Bello / Mansour Abdullah Alshehri / Egwuonwu Afamefuna Victor / Naima Aliyu Umar / Burak Kundakci

    A Systematic Review and Meta-Analysis.docx

    2020  

    Abstract: ... musculoskeletal features. Result: Sixty studies (n = 11, 069) were included in the review, and 51 studies were ... consciousness (95% CI 1–2%; I 2 0%). Conclusion and Relevance: Patients with COVID-19 present with neurological ... Importance: Some of the symptoms of COVID-19 are fever, cough, and breathing difficulty ...

    Abstract Importance: Some of the symptoms of COVID-19 are fever, cough, and breathing difficulty. However, the mechanism of the disease, including some of the symptoms such as the neurological and musculoskeletal symptoms, is still poorly understood. Objective: The aim of this review is to summarize the evidence on the neurological and musculoskeletal symptoms of the disease. This may help with early diagnosis, prevention of disease spread, and treatment planning. Data Sources: MEDLINE, EMBASE, Web of Science, and Google Scholar (first 100 hits) were searched until April 17, 2020. The key search terms used were “coronavirus” and “signs and symptoms.” Only studies written in English were included. Study Selection: The selection was performed by two independent reviewers using EndNote and Rayyan software. Any disagreement was resolved by consensus or by a third reviewer. Data Extraction and Synthesis: PRISMA guidelines were followed for abstracting data and assessing the quality of the studies. These were carried out by two and three independent reviewers, respectively. Any disagreement was resolved by consensus or by a third reviewer. The data were analyzed using qualitative synthesis and pooled using a random-effect model. Main Outcome(s) and Measure(s): The outcomes in the study include country, study design, participant details (sex, age, sample size), and neurological and musculoskeletal features. Result: Sixty studies (n = 11, 069) were included in the review, and 51 studies were used in the meta-analysis. The median or mean age ranged from 24 to 95 years. The prevalence of neurological and musculoskeletal manifestations was 35% for smell impairment (95% CI 0–94%; I 2 99.63%), 33% for taste impairment (95% CI 0–91%; I 2 99.58%), 19% for myalgia (95% CI 16–23; I 2 95%), 12% for headache (95% CI 9–15; I 2 93.12%), 10% for back pain (95% CI 1–23%; I 2 80.20%), 10% for dizziness (95% CI 3–19%; I 2 86.74%), 3% for acute cerebrovascular disease (95% CI 1–5%; I 2 0%), and 2% for impaired consciousness (95% CI 1–2%; I 2 0%). Conclusion and Relevance: Patients with COVID-19 present with neurological and musculoskeletal symptoms. Therefore, clinicians need to be vigilant in the diagnosis and treatment of these patients.
    Keywords Neurology and Neuromuscular Diseases ; Neurogenetics ; COVID-19 ; symptoms ; myalgia ; taste impairment ; anosmia ; cytokine storm ; headache ; muscle weakness ; covid19
    Subject code 333
    Publishing date 2020-06-26T15:45:17Z
    Publishing country uk
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top